Abstract:Oncogene-induced senescence is a tumor-suppressive defense mechanism triggered upon activation of certain oncogenes in normal cells. Recently, the senescence response to oncogene activation has been shown to act as a bona fide barrier to cancer development in vivo. Multiple previous studies have implicated the importance of the p38 MAPK pathway in oncogene-induced senescence. However, the contribution of each of the four p38 isoforms (encoded by different genes) to senescence induction is unclear. In the current study, we demonstrated that p38 alpha and p38 gamma, but not p38 beta, play an essential role in oncogenic ras-induced senescence. Both p38 alpha and p38 gamma are expressed in primary human fibroblasts and are activated upon transduction of oncogenic ras. Small hairpin RNA-mediated silencing of p38 alpha or p38 gamma expression abrogated ras-induced senescence, whereas constitutive activation of p38 alpha and p38 gamma caused premature senescence. Furthermore, upon activation by oncogenic ras, p38 gamma stimulated the transcriptional activity of p53 by phosphorylating p53 at Ser33, suggesting that the ability of p38 gamma to mediate senescence is at least partly achieved through p53. However, p38 alpha contributed to ras-inducted senescence via a p53-indepdendent mechanism in cells by mediating ras-induced expression of p16(INK4A), another key senescence effector. These findings have identified p38 alpha and p38 gamma as essential components of the signaling pathway that regulates the tumor-suppressing senescence response, providing insights into the molecular mechanisms underlying the differential involvement of the p38 isoforms in senescence induction.

PRAK Is Essential for ras-Induced Senescence and Tumor Suppression

PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway.

Induction of P38δ Expression Plays an Essential Role in Oncogenic Ras-Induced Senescence

P38α and P38γ Mediate Oncogenic Ras-Induced Senescence Through Differential Mechanisms

Protein Kinase D1 is Essential for Ras-Induced Senescence and Tumor Suppression by Regulating Senescence-Associated Inflammation

A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Mitogen-Activated Protein Kinase P38 Defines The Common Senescence-Signalling Pathway

The essential role of PRAK in tumor metastasis and its therapeutic potential

Mutant Ras and Inflammation-Driven Skin Tumorigenesis is Suppressed Via a JNK-iASPP-AP1 Axis

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence

Inactivation Of Rheb By Prak-Mediated Phosphorylation Is Essential For Energy-Depletion-Induced Suppression Of Mtorc1

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor

Inactivation of Sag/Rbx2/Roc2 E3 Ubiquitin Ligase Triggers Senescence and Inhibits Kras-Induced Immortalization

The Pathways to Tumor Suppression Via Route P38

Protein kinase D1 phosphorylates CBX8 to facilitate the disassociation of PRC1 complex from p16 promoter and promotes cell senescence

Inactivation of Sag/Rbx2/Roc2 e3 ubiquitin ligase triggers senescence and inhibits kras-induced immortalization.

The Protein Kinase D1-mediated Classical Protein Secretory Pathway Regulates the Ras Oncogene-Induced Senescence Response.

USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras -induced tumorigenicity

RPL23 Links Oncogenic RAS Signaling to P53-Mediated Tumor Suppression